Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells

Eur J Immunol. 2014 Jun;44(6):1575-81. doi: 10.1002/eji.201344365. Epub 2014 May 22.

Abstract

IL-34 is a recently discovered cytokine that acts on tissue resident macrophages and Langerhans cells upon binding the receptor for CSF-1, CSF-1R. The existence of two ligands for CSF-1R, IL-34, and CSF-1, raises several intriguing questions. Are IL-34 and CSF-1 redundant or does each perform temporally and spatially distinct functions? Is IL-34 involved in human pathology? Would therapeutic strategies based on selective inhibition or administration of either IL-34 or CSF-1 be advantageous for preventing human pathology? Recent in vivo studies indicate that IL-34 promotes the development, survival, and function of microglia and Langerhans cells; therefore, this cytokine may predominately function in brain and skin biology. Here, we review the evidence for IL-34 as a key cytokine in the development and function of these two diverse cell types and discuss its potential role in pathological conditions.

Keywords: CSF-1; IL-34; Langerhans cell; M-CSF; Macrophage; Microglia; Osteoclast.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Cell Differentiation / immunology*
  • Humans
  • Interleukins / immunology*
  • Langerhans Cells / cytology
  • Langerhans Cells / immunology*
  • Macrophage Colony-Stimulating Factor / immunology
  • Macrophages / cytology
  • Macrophages / immunology*
  • Microglia / cytology
  • Microglia / immunology
  • Receptor, Macrophage Colony-Stimulating Factor / immunology

Substances

  • IL34 protein, human
  • Interleukins
  • Macrophage Colony-Stimulating Factor
  • Receptor, Macrophage Colony-Stimulating Factor